US$ 29.19
glp-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP1 Receptor Agonists—Effects beyond Obesity
Description
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

Thats because Medicare now covers the drugs, known as GLP-1s, for other medically accepted indications, including to treat diabetes

References Bodnaruc, A.M., Prudhomme, D., Blanchet, R

doi: 10.1172/JCI81975

Improve Liver Function: Treatment with GLP-1s may lead to better liver function

No published safety data for the combination
